A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
NCT02516774
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No patients enrolled
Conditions
Anaplastic Thyroid Cancers
Interventions
DRUG:
Adalimumab
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris